Glabridin content and metabolic effects of liquorice confectionaries: A secondary analysis of a randomized crossover trial in young adults
PLOS One · 2026
DOI: 10.1371/journal.pone.0358710 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, 2026. Verfasst von Anna Åstrand und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Chemistry and Pharmacology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. Hauptthemen laut MEDLINE: Isoflavones, Phenols, Glycyrrhiza, Candy. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Strategic Research Network in Circulation and Metabolism at Linköping University, Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse, Hjärt-Lungfonden.
Abstract (Originalsprache)
Background
Liquorice, a popular confectionary product, contains several bioactive compounds. Amongst them, glycyrrhizic acid is associated with increased blood pressure, and glabridin is associated with anti-inflammatory and glucose-lowering effects. The aim was to assess the association between short term liquorice intake at a dose known to elevate blood pressure, and markers of dysglycemia, blood lipids, high-sensitivity C-reactive protein (hsCRP), and calcium metabolism.
Methods
In a 2x2 crossover study, 28 healthy adults were randomized to consume liquorice or a control product in alternating 2-week periods, with measurements of blood glycated haemoglobin A 1c as well as plasma glucose, calcium ion, parathyroid hormone, and lipids at the end of each period. Liquorice glabridin content was determined via LC-MSMS analysis.
Results
The liquorice contained 0.25 ± 0.14 µg glabridin per mg. The plasma hsCRP value increased by 32.5% (95% CI −9.7 to 74.6) during the intervention period vs 311.5% (95% CI −40.8 to 663.7) during the control period, P = .045. No effects on the other markers were observed.
Conclusion
Liquorice intake did not improve metabolic markers but attenuated hsCRP elevation. The potential metabolic benefits of glabridin are unlikely to outweigh the hypertensive effects when consumed as whole liquorice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Clinical Chemistry and Pharmacology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
- Primary Healthcare Center Cityhälsan Centrum, Region Östergötland, Norrköping, Sweden.
- Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
- Primary Healthcare Center Kärna, Region Östergötland, Linköping, Sweden.
- The George Institute for Global Health, University of New South Wales, Sydney, Australia.
ORCID-Profile: Anna Åstrand, Peder Af Geijerstam
Förderung
- the Strategic Research Network in Circulation and Metabolism at Linköping University
- Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
- Hjärt-Lungfonden
- Primary Health Care Centres research fund, Region Östergötland, Sweden
Zitieren
APA
Åstrand, A., Joelsson, A., Rådholm, K., Nyström, F. H., & Af Geijerstam, P. (2026). Glabridin content and metabolic effects of liquorice confectionaries: A secondary analysis of a randomized crossover trial in young adults. PLOS One. https://doi.org/10.1371/journal.pone.0358710
Vancouver
Åstrand A, Joelsson A, Rådholm K, Nyström FH, Af Geijerstam P. Glabridin content and metabolic effects of liquorice confectionaries: A secondary analysis of a randomized crossover trial in young adults. PLOS One. 2026. doi:10.1371/journal.pone.0358710
BibTeX
@article{strand2026,
author = {Åstrand, Anna and Joelsson, Annelie and Rådholm, Karin and Nyström, Fredrik H and Af Geijerstam, Peder},
title = {Glabridin content and metabolic effects of liquorice confectionaries: A secondary analysis of a randomized crossover trial in young adults},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0358710}
}
EUVIMED